Introduction
N-type voltage gated calcium channels (Ca V 2.2) are expressed predominantly in central and peripheral neurons (Nowycky et al., 1985; Dubel et al., 1992; Westenbroek et al., 1998) . At presynaptic terminals, Ca V 2.2 channels are recruited to the active zone where they are activated upon the arrival of action potentials, triggering influx of Ca 2ϩ through the pore-forming ␣1 subunit and causing neurotransmitter release (Reynolds et al., 1986; Hirning et al., 1988; Hibino et al., 2002; Maximov and Bezprozvanny, 2002; Han et al., 2011; Kaeser et al., 2011) . Neurons are morphologically complex cells that are highly polarized for their specialized functions, and several studies have elucidated how Ca V 2.2 channels are targeted to the plasma membrane where they are required. The association of Ca V 2 channels with auxiliary subunits, ␤ and ␣ 2 ␦, is thought to be important not only for the biophysical properties, but also for correct intracellular trafficking of the channels (De Waard et al., 1994; Gurnett et al., 1996; Dolphin, 2012; Cassidy et al., 2014) . Furthermore, interaction of Ca V 2.2 with G-protein-coupled receptors (GPCRs) is also reported to influence the cell surface expression of Ca V 2.2 (Altier et al., 2006; Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008; . However, the precise mechanisms of Ca V 2.2 trafficking between intracellular organelles and the plasma membrane are poorly understood.
Posttranscriptional modification such as alternative splicing provides Ca V 2.2 with further functional variation, which finetunes neuronal excitability. To elucidate how Ca V 2.2 channels are trafficked to the plasma membrane in neurons, we investigated whether there are differences in trafficking between two Ca V 2.2 alternative splice variants of exon 37 in the proximal C terminus of Ca V 2.2, which is alternatively spliced in a mutually exclusive manner to give rise to Ca V 2.2 channels that contain either exon 37a (e37a) or exon 37b (e37b; Fig. 1A ; Lipscombe et al., 2002; Bell et al., 2004) . This introduces a relatively restricted change in the amino acid sequence, but nevertheless, Ca V 2.2e37a has a larger whole-cell current compared to Ca V 2.2e37b (Bell et al., 2004; Raingo et al., 2007; Marangoudakis et al., 2012) . Expression of exon 37a-containing Ca V 2.2 channels is enriched in small dorsal root ganglion (DRG) neurons, including nociceptors (Bell et al., 2004; Altier et al., 2007) . We noted that the exon 37a sequence introduces two canonical adaptor protein (AP) motifs that are absent from exon 37b. Together with several lines of evidence that the C terminus of Ca V channels is important in channel targeting (Bourinet et al., 1999; Gao et al., 2000; Kepplinger et al., 2000; Krovetz et al., 2000; Hall et al., 2013) , we hypothesized that Ca V 2.2 channels containing e37a may be more readily trafficked to the plasma membrane compared to Ca V 2.2e37b channels by virtue of these motifs.
To demonstrate whether alternative splicing regulates trafficking of Ca V 2.2, we took advantage of our recently developed functional exofacially tagged Ca V 2.2 channels (Cassidy et al., 2014) to visualize their cellular localization in both Neuro2a (N2a) cells and DRG neurons. We used electrophysiological, immunocytochemical, and livecell labeling approaches to demonstrate that Ca V 2.2 channels containing e37a are trafficked more readily than those with e37b to the plasma membrane and to the processes of DRG neurons, as a result of enhanced forward trafficking from the Golgi apparatus to the plasma membrane. We also reveal that this trafficking pathway is indeed dependent on specific motifs in e37a that mediate interaction with AP-1, which is involved in clathrin-mediated protein sorting (Bonifacino and Traub, 2003) . Furthermore, we also present evidence that the dopamine-2 receptor (D2R) has a stabilizing effect on Ca V 2.2e37b channels, leading to increased cell surface expression, but notonCa V 2.2e37achannels,andthiseffectonendocytosisisreversedby D2R activation. Our data suggest that D2R activation-mediated internalization of Ca V 2.2 involves interaction between AP-2 and the AP binding motifs in the proximal C terminus of Ca V 2.2. Together, we provideevidenceforinvolvementoftheAP-familyinCa V 2.2trafficking, which is modulated by alternative splicing.
Materials and Methods
Constructs. The following cDNA plasmids were used: Ca V 2.2 (D14157), ␤1b (X61396 , from T. P. Snutch, University of British Columbia, Vancouver, Canada), ␣ 2 ␦-1 (M86621), and D2R (NM_012547). All the cDNAs were subcloned into pMT 2 expression vectors for tsA-201 transfection, and into pcDNA3.0 or pRK5 expression vectors for N2a and DRG transfection. Hemagglutinin (HA)-and bungarotoxin-binding site (BBS)-tagged Ca V 2.2 were generated as described previously (Cassidy et al., 2014) . Green fluorescent protein (GFP)-HA-tagged Ca V 2.2 was generated by subcloning HA-Ca V 2.2 into the N terminus of GFP-Ca V 2.2 (Raghib et al., 2001 ) by restriction digest. Ca V 2.2e37a AP binding motif mutants were generated using the primers shown in Table 1 at the following locations: Y1775A (Y/A), L1777A (L/A), L1777A/L1778A (LL/AA), and Y1775A/L1777A/L1778A (YSLL/ASAA). AP-1a shRNA with mCerulean in pSUPER vector was a gift from M. A. Cousin (University of Edinburgh, Edinburgh, UK) (Cheung and Cousin, 2012) . The scrambled AP-1 shRNA was generated from the primers containing BglII and HindIII sites (Table 1 ). The PCR product was subcloned into pSUPER expression vector. AP-1 1A WT and V98S in pcDNA3.1 vectors were gifts from J. S. Bonifacino (NIH, Bethesda, MD) (Jain et al., 2015) . AP-2 2 WT and F176A/D178S in pcDNA3.1 vectors were gifts from M. S. Robinson (Cambridge University, Cambridge, UK) (Motley et al., 2006). All constructs were verified by DNA sequencing.
Cell culture and transfection. tsA-201 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 1 unit/ml penicillin, 1 g/ml streptomycin, and 1% GlutaMAX (Invitrogen). tsA-201 cells were transfected using Fugene 6 (Promega) according to the manufacturer's protocol. Mouse neuroblastoma N2a cells were cultured in 50% DMEM and 50% Opti-MEM supplemented with 5% FBS, 1 unit/ml penicillin, 1 g/ml streptomycin, and 1% GlutaMAX. N2a cells were transfected using PolyJet (SignaGen Laboratories) according to the manufacturer's protocol. Transfected cells were plated onto coverslips or glass-bottomed dishes (MatTek) coated with poly-L-lysine and cultured in a 5% CO 2 incubator at 37°C. Postnatal day 10 DRG neurons were isolated from male Sprague Dawley rats and transfected with Amaxa Nucleofector (Lonza) according to the manufacturer's protocol. Transfected neurons were plated on the coverslips coated with poly-L-lysine and cultured in DMEM/F-12 supplemented with 10% FBS, 1 units/ml penicillin, 1 g/ml streptomycin, 1% GlutaMAX, and 100 ng/ml NGF in a 5% CO 2 incubator at 37°C. Pertussis toxin (PTX) treatment involved 16 h incubation with 500 ng/ml PTX before the experiment.
Western blotting. After 40 -48 h expression, cells were harvested in PBS containing Complete Protease Inhibitor Cocktail (PI; Roche; 1 tablet/50 ml). The cells were lysed in cell lysis buffer [50 mM Tris, pH 7.4, 50 mM NaCl, PI, 1% IGEPAL CA-630 (octylphenoxypolyethoxyethanol), 25 mM N-ethylmaleimide] by sonication and were then left on ice for 45 min. The cell lysate was clarified by centrifugation at 14,000 ϫ g for 20 min. Protein samples were denatured by heating at 55°C for 15 min with reducing Laemmli sample buffer (2% SDS, 2% glycerol, 0.02% bromophenol blue, 50 mM Tris HCl, pH 6.8, 20 mM DTT). Proteins were separated on a 3-8% Trisacetate gel (Invitrogen) and transferred onto a polyvinylidene fluoride membrane. The membrane was blocked in Tris-buffered saline solution (10 mM Tris, pH7.4, 500 mM NaCl, 0.5% IGEPAL CA-630) with 3% BSA and was then incubated with the primary antibody (1:1000) overnight at 4°C. The secondary antibody conjugated with horseradish peroxide (HRP; 1:3000) was incubated with the membrane at room temperature for 1 h. The proteins were detected using ECL Plus Western blotting detection reagents (GE Healthcare) according to the manufacturer's protocol and scanned using the fluorescent detection mode on a Typhoon 9410 (GE Healthcare). Primary antibodies used were rabbit anti-Ca V 2.2 II-III loop (Raghib et al., 2001 ) and mouse anti-GAPDH. Secondary antibodies used were goat anti-rabbit-HRP and goat anti-mouse-HRP (Invitrogen).
Immunocytochemistry. After 40 -72 h expression, cells were fixed with 4% paraformaldehyde (PFA) in PBS, pH7.4, at room temperature for 10 min. For labeling the HA epitope on the cell surface in nonpermeabilized conditions, the cells were incubated with primary antibody with 2.5% BSA and 10% goat serum in PBS at room temperature for 1 h for N2a cells, or overnight at 4°C for DRG neurons. The secondary antibody was added with 2.5% BSA and 10% goat serum in PBS and incubated for 1 h at room temperature. In experiments in which the D2R was activated, 100 nM quinpirole (Quin; Sigma-Aldrich) was added to N2a cells in Krebs-Ringer solution with HEPES [KRH; containing (in mM) 125 NaCl, 5 KCl, 1.1 MgCl 2 , 1.2 KH 2 PO 4 , 2 CaCl 2 , 6 glucose, 25 HEPES, and 1 NaHCO 3 ] at 37°C for 30 min. PTX (500 ng/ml; Invitrogen) was added to the cells in the culture media overnight. To label intracellular proteins, the cells were permeabilized with 0.2% Triton X-100 in PBS for 10 min. The primary and secondary antibodies in 2.5% BSA and 10% goat serum were added to the cells as above. Cell nuclei were stained with 0.5 M DAPI (4Ј,6Ј-diamidino-2-phenylindole) in PBS for 10 min. The coverslips were mounted onto glass slides using Vectashield mounting medium (Vector Laboratories). Primary antibodies used were rabbit anti-Ca V 2.2 (Raghib et al., 2001) , rat anti-HA (Roche; 1:500) or mouse anti-Myc 9E10 (Santa Cruz Biotechnology; 1:100). Secondary antibodies (1:500) used were Alexa Fluor 594 anti-rabbit, Alexa Fluor 594 anti-rat, Alexa Fluor 647 antimouse (Invitrogen), or FITC anti-rat (Sigma-Aldrich).
Endocytosis and forward trafficking assay. After 40 h expression, N2a cells in glass-bottomed dishes were washed twice with KRH. For the endocytosis assay, cells were incubated with 10 g/ml ␣-bungarotoxin Alexa Fluor 488 conjugate (BTX488; Invitrogen) at 17°C for 30 min. The unbound BTX488 was removed by washing with KRH, and the labeled cells were returned to 37°C for the kinetic assay. Endocytosis was stopped by fixing the cells with cold 4% PFA in PBS at the specified time. For endocytosis experiments in which the D2R was activated, 100 nM Quin was added to the cells in KRH Figure 1 . Alternative splicing in Ca V 2.2 exon 37 and electrophysiological properties of Ca V 2.2e37a and e37b. A, Mutually exclusive alternative splicing in Ca V 2.2 exon 37 and an alignment of exon 37a and 37b amino acid sequences. B, Representative whole-cell current recordings (left) and mean current-voltage relationship (right) for Ca V 2.2e37a and Ca V 2.2e37b in tsA-201 cells with ␣ 2 ␦-1 and ␤1b [peak current density (pA/pF), e37a (red), Ϫ245.0 Ϯ 29.1 (ϩ5 mV, n ϭ 22); e37b (blue), Ϫ156.0 Ϯ 17.7 (ϩ10 mV, n ϭ 24)]. C, The G max of e37a was significantly larger than that of e37b ( p ϭ 0.0189). D, V 50,act of e37a was significantly hyperpolarized compared with e37b ( p ϭ 0.0009). E,D 2 receptor-mediated inhibition of Ca V 2.2e37 isoforms. Whole-cell current was recorded before and after 300 nM quinpirole treatment. The voltage-clamp protocol is shown on the top. The exemplary current traces of Ca V 2.2e37b (black, control; blue, 300 nM Quin) and Ca V 2.2e37a (gray, control; red, 300 nM Quin) are also shown. The relative current expressed as P2/P1 was significantly smaller for Ca V 2.2e37a (n ϭ 19) compared to Ca V 2.2e37b (n ϭ 22) in the presence of 300 nM Quin ( p ϭ 0.0101), showing that the inhibition of Ca V 2.2e37a is more voltage-independent. n, Number of cells. *p Ͻ 0.05; ***p Ͻ 0.001 (Student's unpaired t test).
buffer after the BTX488 labeling stage. For the forward trafficking assay, the cells were incubated with 10 g/ml unlabeled ␣-bungarotoxin (BTX; Invitrogen) at 17°C for 30 min. The unbound BTX was washed off with KRH, and the cells were then incubated with 10 g/ml BTX488 in KRH at 37°C. To stop the reaction, cells were washed twice with cold KRH and then fixed with 4% PFA in PBS at specified times for the kinetic assay. Brefeldin A [BFA; 200 ng/ml (0.71 M); Sigma-Aldrich] in 0.4% DMSO was added to the cells in FBS-free N2a cell culture medium for 4 h before the experiment, and during the experiment in KRH buffer. The cells were then permeabilized, and intracellular Ca V 2.2 and nuclei were labeled as described above. The 13 mm coverslips were mounted onto dishes using Vectashield mounting medium.
Confocal microscopy and image analysis. All images were acquired using an LSM 780 Meta scanning confocal microscope (Zeiss) equipped with a Plan-Apochromat 63ϫ/1.4 numerical aperture (NA) or 40ϫ/1.3 NA differential interference contrast (DIC)II oil-immersion objective lens in 16-bit mode (Cassidy et al., 2014) . The laser powers, gains, and acquisition settings were kept constant for images that were used subsequently for quantification. For cell surface expression analysis, images were taken with 0.7 m optical sections. For neurite expression analysis, images were taken with 0.9 m optical sections in Z-stack and presented as maximum projections. Confocal images were imported and analyzed in ImageJ (NIH). The membrane fluorescence was quantified using the freehand brush tool with a selection width of 0.66 m and tracing the membrane region manually to acquire the fluorescence density, which is independent of cell circumference. Neurite fluorescence intensity was quantified using the freehand brush tool with a selection with of 2 m and manually tracing the entire neurites using mCherry expression as a marker. Intracellular and whole-cell fluorescence densities were quantified using freehand selection, omitting the signal intensity from the nuclei. The background fluorescence density in each channel was also taken from the same image and subtracted from the signal density. For the endocytosis and forward trafficking assays, the normalized membrane fluorescent intensities were fitted to a single exponential. The forward trafficking rates were derived from the reciprocal of the time constant () of the single exponential (1/).
Electrophysiology. After 40 h expression, cells were replated in cell culture medium at a 1 in 3 or 5 dilution, depending on their confluency. Transfected cells were identified by coexpression of CD8, which was detected with CD8 Dynabeads (Invitrogen). Whole-cell currents were recorded in voltage-clamp mode in following solutions: intracellular (electrode) solution (in mM), 140 Cs-aspartate, 5 EGTA, 2 MgCl 2 , 0.1 CaCl 2 , 2 K 2 ATP, 20 HEPES, pH 7.2, 310 mOsm; extracellular solution (in mM), 1 BaCl 2 , 3 KCl, 1 NaHCO 3 , 1 MgCl 2 , 10 HEPES, 4 D-glucose, 160 tetraethylammonium bromide, pH 7.4, 320 mOsm. The borosilicate glass electrode resistance was between 1.5 and 4 M⍀. Cell capacitance and series resistance were compensated to 80%. Whole-cell currents were recorded with an Axopatch-200B amplifier using pClamp 9 or 10 (Molecular Devices). The cells were held at Ϫ90 mV, and 50 ms pulses were applied in ϩ5 mV steps between Ϫ30 and ϩ70 mV. For D2R activation, Quin was applied by local application through a perfusion system. To correct for the leak current, a P/8 leak subtraction protocol was applied. Recordings were filtered at 5 kHz (low-pass four-pole Bessel filter) in the amplifier. The digital low-pass eight-pole Bessel filter with a 1 kHz, 3 dB cutoff was applied in Clampfit 10.9 (Molecular Devices) before the current amplitudes were determined. Average peak currents were taken between 8 and 13 ms after the test potentials were applied and normalized to the cell capacitance to obtain the current density. Current-voltage ( I-V) relationships were fitted to the following modified Boltzmann equation to give V 50 activation (V 50,act ), conductance (G max ), and reversal potential (V rev ) using Origin 7:
Immunocytochemistry and trafficking experiments with N2a cells were repeated with n ϭ 3-5 transfections, and ϳ30 to 50 cells were analyzed for each experiment. All data were presented as pooled in the result graphs except for the trafficking rates and time constants, which are averages of separate experiments. Statistical analysis was performed using either Student's unpaired t test or one-way ANOVA with Bonferroni's post hoc test as appropriate in GraphPad Prism. All the data are expressed as mean Ϯ SEM.
Results

Exofacially tagged Ca V 2.2 channels containing e37a conduct a larger whole-cell current than those containing e37b
To compare the localization of Ca V 2.2 isoforms containing e37a or e37b (Fig. 1A) , both channels were exofacially tagged with HA or BBS tags as described previously (Cassidy et al., 2014) . First, to demonstrate that the exofacial tag does not affect the function of the Ca V 2.2 splice variant channels, whole-cell Ba 2ϩ currents were recorded from tsA-201 cells transiently expressing HA-tagged Ca V 2.2e37a and Ca V 2.2e37b, together with the auxiliary subunits ␣ 2 ␦-1 and ␤1b. The average whole-cell current density of Ca V 2.2e37a was significantly larger than that of Ca V 2.2e37b at test potentials between Ϫ25 and 15 mV (Fig. 1B) , and the average whole-cell conductance (G max ) for Ca V 2.2e37a currents was ϳ1.5-fold greater than that for Ca v 2.2e37b currents (Fig. 1C) . Furthermore, Ca v 2.2e37a channels were activated at a more hyperpolarized potential than those containing e37b (Fig. 1D ). These properties of Ca V 2.2e37a and e37b currents are in agreement with the previous reports in expression systems (Bell et al., 2004; Raingo et al., 2007) and in transgenic mice (Andrade et al., 2010) .
Moreover, these tagged Ca V 2.2 isoforms also exhibited differential voltage-dependence upon G-protein-coupled receptor (GPCR) activation, in a similar manner to that reported previously (Raingo et al., 2007; Andrade et al., 2010) . Using a double pulse protocol, in the presence of the D2R, Ca V 2.2e37a and Ca V 2.2e37b currents [in the first test pulse (P1)] were inhibited by a D2R-specific agonist, quinpirole. When a large depolarizing pulse was applied just before the second test pulse (P2) in the presence of Quin, Ca v 2.2e37a exhibited significantly smaller relative currents (P2/P1), compared to Ca V 2.2e37b (Fig. 1E ). This voltage-independent inhibition of Ca V 2.2e37a by D2R activation largely agrees with previous findings with GABA B and -opioid receptor activation in expression systems and in transgenic mice (Raingo et al., 2007; Andrade et al., 2010) . These results demonstrate that the Ca V 2.2e37 isoforms containing exofacial tags function as predicted by previous studies.
Ca V 2.2e37a channels are preferentially expressed at the cell membrane To investigate whether the increased current exhibited by Ca V 2.2e37a results from an effect on trafficking, mediating altered cellular localization of the Ca V 2.2e37 isoforms, we added GFP to the N terminus of the Ca V 2.2 splice variants containing the exofacial HA 
The forward (F) and reverse (R) primers used in generating the constructs described in Materials and Methods are shown here.
tag ( Fig. 2A ). The advantage of these constructs is that expression of the channel at the plasma membrane can be detected by immunostaining for the cell surface HA epitope in nonpermeabilizing conditions after fixation and the total channel localization determined by GFP simultaneously. These tagged Ca V 2.2 isoforms were transiently expressed in neuronal cell line N2a in the presence of ␣ 2 ␦-1 and ␤1b ( Fig. 2A ). This revealed a larger plasma membrane expression level of Ca v 2.2e37a compared to Ca v 2.2e37b, without altering the whole-cell expression level of the channels (Fig. 2B ). GFP at the N terminus did not alter this cellular localization pattern, as the same observation was made from cells expressing the HA-tagged Ca V 2.2 isoforms, in which the intracellular channels were immunolabeled with anti-Ca V 2.2 II-III loop antibody, after permeabilization (Fig.  2C ). This confirmed that Ca V 2.2 channels containing e37a are preferentially localized in the plasma membrane and that the increase in the cell surface expression is not due to the overall increase in the protein expression level. Preferential expression of Ca V 2.2e37a at the cell membrane was also exhibited in the cell bodies of isolated cultured DRG neurons expressing the HA-tagged GFP-Ca V 2.2 isoforms (Fig. 3A,B) . The amount of tagged Ca V 2.2e37a channels in the neurites of these DRG neurons was also significantly higher than for Ca V 2.2e37b, without altering the level of an expression marker mCherry that was cotransfected to visualize the entire field of neurites (Fig. 3C,D) . Ca V 2.2e37a channels were also expressed significantly further away from the soma in these neurites, compared to Ca V 2.2e37b (Fig. 3E) . In summary, Ca V 2.2e37a channels in the DRG neurons were trafficked further along the neurites, as well as to the plasma membrane of the cell bodies, to a significantly greater degree than Ca V 2.2e37b channels.
␣ 2 ␦-1 is essential for the underlying mechanism of differential Ca V 2.2 isoform trafficking Auxiliary ␣ 2 ␦ subunits play an important role in Ca V 2.2 trafficking (Dolphin, 2012; Cassidy et al., 2014) . To determine whether ␣ 2 ␦-1 is required for the differential cell surface expression of Ca V 2.2e37a channels, HA-tagged Ca V 2.2e37 isoforms were coexpressed plus ␤1b, with or without ␣ 2 ␦-1 in tsA-201 cells. The average whole-cell G max for both isoforms in the absence of ␣ 2 ␦-1 was significantly reduced, and the difference in conductance between e37a and e37b was lost (Fig. 4 A, B) . Similarly, in N2a cells, immunostaining of the cell surface HA-Ca V 2.2 revealed that the increased plasma membrane expression of Ca V 2.2e37a, relative to Ca V 2.2e37b, was lost in the absence of ␣ 2 ␦-1 (Fig. 4C,D) . Thus, ␣ 2 ␦-1 is required for underlying mechanisms involved in the differential trafficking of Ca V 2.2e37a, possibly via interaction through intermediate protein(s) and utilization of the same pathway(s) involved in transporting the channels to the plasma membrane.
Ca V 2.2e37a shows greater net forward trafficking to the cell membrane To investigate the mechanism of differential Ca V 2.2 splice variant trafficking, BBS-tagged Ca V 2.2 constructs were expressed in N2a cells, in which the channels can be live-labeled directly with 2 of GFP-HA-Ca V 2.2e37 isoforms. Cell surface HA and total GFP fluorescence intensities were quantified and normalized to the average intensity value of Ca V 2.2e37b from each experiment. Cell surface expression of GFP-HA-Ca V 2.2e37a was significantly greater than that of e37b ( p ϭ 0.0174). C, Cell surface (left) and total (right) Ca V 2.2 levels for HA-Ca V 2.2 isoforms, expressed in arbitrary units. Cell surface expression of HA-Ca V 2.2e37a was significantly greater than that of e37b ( p ϭ 0.0050), and the GFP at the N terminus did not affect the trafficking patterns for Ca V 2.2e37 isoforms. n, Number of cells. *p Ͻ 0.05; **p Ͻ 0.01 (Student's unpaired t test).
BTX488, to monitor the net appearance of the channels in the plasma membrane over time, after saturating the channels already on the surface with unlabeled BTX (Fig. 5A) . In this protocol, the initial rate of appearance of Ca V 2.2e37a on the cell surface was greater than for Ca V 2.2e37b, leading to a greater steady-state maximum cell surface expression level (Fig. 5B) . These results imply that the increased presence of Ca V 2.2e37a on the cell surface is due to an increased trafficking from subcellular organelles to the plasma membrane. Since the AP binding motifs in the Ca V 2.2e37 isoforms are also recognized by AP-2, another mem- . Ca V 2.2e37a is trafficked more readily than Ca V 2.2e37b to the plasma membrane of the soma and to the neuronal processes of DRG neurons. A, Confocal images of DRG cell bodies expressing GFP-HA-Ca V 2.2 isoforms with ␣ 2 ␦-1 and ␤1b. B, Normalized cell surface and total Ca V 2.2 in cell bodies. The cell surface HA and total GFP fluorescence densities were quantified and normalized to the average intensity value of Ca V 2.2e37b from each experiment. Cell surface expression of GFP-HA-Ca V 2.2e37a in the DRG somata was significantly greater than that of e37b ( p ϭ 0.0277). C, Confocal images of DRG neurites expressing GFP-HA-Ca V 2.2 isoforms with free mCherry. D, Total fluorescence of Ca V 2.2 isoforms and free mCherry in the neurites (in ϫ10 7 a.u.). Total GFP-HA-Ca V 2.2e37a in the DRG neurites was significantly greater than e37b ( p ϭ 0.0038). E, Total length of DRG neurites showing expression of GFP-HA-Ca V 2.2e37 isoforms. Ca V 2.2e37a channels were expressed further away from the soma than e37b channels ( p ϭ 0.0436). Scale bars: A, C, 20 m. n, Number of cells. *p Ͻ 0.05; **p Ͻ 0.01 (Student's unpaired t test).
ber of the AP family that is involved in endocytosis, the basal rates of endocytosis of the two isoforms were compared. Ca V 2.2e37a and Ca V 2.2e37b showed similar kinetics of endocytosis (Fig.  5C ,D, Table 2 ), indicating that this did not contribute significantly to the observed differences in net forward trafficking.
Brefeldin A reduces cell surface expression of Ca V 2.2 splice variants
The two main sources of transmembrane proteins inserted into the plasma membrane are (1) newly synthesized proteins from the endoplasmic reticulum (ER) and the Golgi apparatus (Guo et al., 2014) and (2) recycled proteins via recycling endosomes (Grant and Donaldson, 2009) . BFA, which disrupts the structure of the Golgi apparatus and inhibits the translocation of proteins from the ER to the plasma membrane (Fujiwara et al., 1988; Lippincott-Schwartz et al., 1989) , was then used to further elucidate the mechanism of differential Ca V 2.2e37a net forward trafficking. As expected, in the presence of BFA, the maximum level of Ca V 2.2 splice variants appearing on the plasma membrane was markedly reduced compared to the control condition (Fig. 5D ). This shows that approximately half of the channel population at the plasma membrane originated from the recycling endosomes within the duration of these experiments. Furthermore, in the presence of BFA, the difference between Ca V 2.2e37a and Ca V 2.2e37b in the maximum cell surface level achieved was abolished. In addition, the kinetics of Ca V 2.2e37a net trafficking to the plasma membrane were markedly slowed compared to those in the absence of BFA (Fig. 5E ). BFA inhibits ADP ribosylation factor 1 (Arf1), which is essential for the recruitment of AP-1, which mediates clathrin-dependent cargo sorting (Zhu et al., 1998; . These observations raised the possibility that the greater forward trafficking and increased cell surface expression of Ca V 2.2e37a, relative to Ca V 2.2e37b, are due to differences in sequence of the proximal C terminus of Ca V 2.2 as a result of alternative splicing, and that the underlying mechanism may involve AP-mediated sorting. . The forward trafficking of Ca V 2.2e37a isoforms is reduced by BFA. A, Confocal images of N2a cells expressing BBS-tagged Ca V 2.2e37 isoforms at different time points after the start of the net forward trafficking assay, showing the appearance of Ca V 2.2 at the cell surface by BTX488 live labeling. B, Left, Kinetics of Ca V 2.2e37 isoform net forward trafficking. The kinetic curves were fitted to a single exponential to derive time constant (minutes). The rates of net forward trafficking (1/,inmin Ϫ1 ) were as follows: e37a (red), 0.212 Ϯ 0.027 (n ϭ 3); e37b (blue), 0.132 Ϯ 0.036 (n ϭ 3 transfections). As a negative control (blue open circle), e37b was kept at 4°C after the start of the experiment. Right, The initial rates of net forward trafficking of Ca V 2.2 isoforms in N2a cells were determined by taking the gradient of the linear regression from the initial linear phase of each forward trafficking kinetic curve. [Ca V 2.2e37b (blue), 116.6 Ϯ 3.1 a.u./min; Ca V 2.2e37a (red), 207.7 Ϯ 20.3 a.u./min; n ϭ 3 transfections]. *p ϭ 0.0114 (Student's unpaired t test). C, Endocytosis of Ca V 2.2e37 isoforms and AP-binding mutants. Representative confocal images of N2a cells expressing BBS-tagged Ca V 2.2e37 isoforms at different time points after the start of an endocytosis assay, showing the disappearance of BTX488-labeled Ca V 2.2 from the cell surface. D, The endocytosis kinetics of Ca V 2.2e37 isoforms. All cell surface intensities were normalized to Ca V 2.2e37b at t ϭ 0 min in each experiment. The time constants () from fitting a single exponential were as follows (in min): e37a (red), 7.00 Ϯ 1.23; e37b (blue), 11.6 Ϯ 3.53 (n ϭ 3 transfections). e37b (open blue circle) was kept at 4°C as a negative control after the start of endocytosis experiment. E, Left, Kinetics of Ca V 2.2e37 isoform net forward trafficking in the presence of BFA (open red circle, e37a ϩ BFA; open blue circle, e37bϩBFA). Controls without BFA at 60 min are also shown for each isoform (red circle, 37a; blue circle, 37b). Right, The net forward trafficking rate of Ca V 2.2e37a isoforms with and without BFA. The time constants () of the single exponentials from Figure 5 , B and E were determined, and the rates were obtained by the reciprocal of (1/ (Janvier et al., 2003) . We noted that both these canonical motifs (Yxx⌽ and [DE] xxxL [LI] ) are present in the e37a sequence DMYSLL (Fig. 1A) , supporting the possibility of interaction with APs. Interestingly, Ca v 2.2e37a contains both motifs in an overlapping manner, whereas Ca V 2.2e37b contains only a noncanonical [DE] xxxL [LI] motif where LL is substituted by ML (Motta et al., 1995; Hofmann et al., 1999) . BFA disrupts AP-1-mediated sorting in the Golgi network, and the reduction in the maximum level of Ca V 2.2 detected at the plasma membrane in the presence of BFA implicated a role for AP-1 in Ca V 2.2 trafficking to the plasma membrane.
AP-
To examine the involvement of AP-1 in Ca V 2.2 trafficking, AP-1␥ shRNA was coexpressed with HA-tagged Ca V 2.2e37 isoforms to knock down the expression of the key subunit for AP-1 interaction with [DE] xxxL [LI] (Cheung and Cousin, 2012) . The cell surface Ca V 2.2 levels were compared to a control in which scrambled AP-1␥ shRNA was coexpressed. AP-1␥ shRNA reduced the AP-1␥ (or ␥-adaptin) expression level by ϳ50% (Fig. 6A) and caused a modest but significant reduction in the cell surface expression of both Ca V 2.2e37 isoforms (Fig. 6B) . To confirm the interaction between AP-1 and Ca V 2.2, the AP-1 dominant-negative mutant V98S was coexpressed with the Ca V 2.2e37 isoforms in N2a cells, to impair the interaction with [DE] xxxL [LI] . This construct has been shown to disrupt the somatodendritic trafficking of the cargoes in hippocampal neurons (Jain et al., 2015) . AP-1 V98S significantly reduced the cell surface expression of both Ca V 2.2e37 isoforms by ϳ50%, relative to those that were coexpressed with the wild-type AP-1 (Fig.  6C,D) . The disrupted trafficking of both Ca V 2.2 isoforms, as a result of the impairment of AP-1 function, suggests that trafficking of both isoforms is mediated by AP-1 and that the noncanonical DxxxML motif in Ca V 2.2e37b may also function, albeit less efficiently, as an AP-1 binding motif and be involved in trafficking to the plasma membrane.
Mutations in AP binding motifs in the C terminus of Ca V 2.2e37a reduce the cell surface expression and the wholecell currents through Ca V 2.2 Since the Ca V 2.2e37a sequence contains both Yxx⌽ and [DE]xxxL[LI] motifs, we mutated key residues to identify which motif is important in AP-1 interaction and to elucidate the mechanism of Ca V 2.2 channel trafficking. In total, 4 Ca V 2.2e37a mutants were created, mutating DMYSLL to DMASLL (Y/A), DMYSAL (L/A), DMYSAA (LL/AA), and DMASAA (YSLL/ ASAA) (Fig. 7A) . The L/A mutant is only able to interact with AP-1, and the Y/A mutant can only interact with AP-1␥, whereas the LL/AA and YSLL/ASAA mutants completely abolish the interaction with AP-1 via these motifs. The cell surface and whole-cell expression levels of these four mutants and the wildtype Ca V 2.2e37a (all coexpressed with ␣ 2 ␦-1 and ␤1b) were determined by Western blot and immunocytochemistry (Fig.  7 A, B) . The plasma membrane expression levels of the L/A and Y/A mutants were ϳ50% of the WT, and the LL/AA and YSLL/ ASAA mutants were almost undetectable at the cell surface (Fig.  7 B, C, left) , despite the intracellular expression levels of all mutants showing no significant difference relative to the WT Ca V 2.2e37a (Fig. 7C, right) . The overall expression levels of these mutants were also similar with each other in the Western blot, but slightly reduced particularly for the YSLL/ASAA mutant compared to the WT, although the reduction was not statistically significant (Fig. 7A) . This may reflect the smaller number of cells in which intracellular Ca V 2.2 expression was detected in N2a cells, particularly for this mutant, as mutations in these motifs can lead to missorting of the proteins, which are then degraded (Braulke and Bonifacino, 2009). We therefore took the L/A, Y/A, and LL/AA mutants forward to further investigate the function and trafficking of these mutants.
To investigate whether the reduced plasma membrane expression of these Ca V 2.2 mutants leads to a parallel reduction in function, we recorded the whole-cell current of the L/A, Y/A, and LL/AA mutants expressed in tsA-201 cells in the presence of ␣ 2 ␦-1 and ␤1b. No current was detected from the LL/AA mutant (Fig. 7D) , as predicted from the imaging experiments (Fig. 7C) . The L/A and Y/A mutations caused the Ca V 2.2 peak currents and G max to be significantly reduced, compared to the WT Ca V 2.2e37a (Fig. 7 D, E) . The V 50 activation voltages were not altered for these mutants (Fig. 7F ). These results demonstrate that AP interaction is involved in the trafficking of Ca V 2.2e37a to the cell surface in the presence of the auxiliary subunits, and the reduced cell current density is due to the lower density of channels in the plasma membrane.
Expression of Ca V 2.2 AP-1 binding motif mutants in DRG neurons is reduced at the plasma membrane of the soma and in the neurites as a result of diminished net forward trafficking
To confirm that the mutations in the AP-1 binding motifs at the proximal C terminus of Ca V 2.2 have an effect on channel trafficking in neurons, these mutant Ca V 2.2 channels were also tagged with GFP at the N terminus. DRG neurons were transfected with HA-tagged GFP-Ca V 2.2 mutants in the presence of ␣ 2 ␦-1 and ␤1b (Fig. 8A) . Immunostaining for HA revealed that in the cell bodies of DRG neurons, expression of all mutants at the plasma membrane was reduced, particularly for the LL/AA mutant, without significantly affecting the total expression levels of the channels (Fig. 8B) . Furthermore, a significantly lower level of these mutants was observed in the neurite compartment, and expression in neurites was confined much closer to the cell bodies, relative to WT (Fig. 8C-E) , suggesting that these motifs are crucial for Ca V 2.2 trafficking along the neurites as well.
The L/A and Y/A mutants were also tagged with the exofacial BBS tag to investigate how these mutations affect intracellular trafficking of Ca V 2.2e37a. The appearance of the mutant channels on the plasma membrane was significantly slower than for WT Ca V 2.2e37a, leading to a reduction in the maximum density of cell surface channels (Fig. 8F ) . The slower overall rates of forward trafficking kinetics for these mutants, compared to WT Ca V 2.2e37a (Fig. 8F, inset) , were similar to that for WT Ca V 2.2e37a in the presence of BFA (Fig. 5E) . Furthermore, the average time constant for endocytosis was approximately doubled for the Ca V 2.2e37a L/A mutant, and more than tripled for the Y/A mutant, compared to WT Ca V 2.2e37a (Fig. 8G, Table 2 ). This observation could be explained by the action of AP-2, which is also able to recognize and interact with both Yxx⌽ and [DE] Ca V 2.2e37a. In summary, AP binding motifs at the C terminus of Ca V 2.2 control the intracellular trafficking of Ca V 2.2, and mutations to these sites disrupt the trafficking to the cell surface and to the distal ends of neurites.
Effect of D2R coexpression and activation on trafficking of Ca V 2.2 splice variants
We next examined whether Ca V 2.2 endocytosis stimulated by activation of GPCRs would be differentially affected for the Ca V 2.2e37 isoforms. Previous studies demonstrated that both D 1 Figure 6 . AP-1 knockdown and the dominant-negative AP-1 mutant reduce Ca V 2.2 trafficking to the plasma membrane. A, Knockdown of AP-1␥ (or ␥-adaptin) by AP-1 shRNA. AP-1␥ shRNA expressed in N2a cells reduced the ␥-adaptin expression level by ϳ44%, compared to the ␥-adaptin expression level in the scrambled shRNA condition. The expression of shRNA detected by mCerulean was comparable in all conditions (scrambled shRNA, closed bar, n ϭ 56; AP-1 shRNA, open bar, n ϭ 59; p Ͻ 0.0001). B, AP-1␥ shRNA significantly reduces cell surface expression of both Ca V 2.2e37 isoforms. Cell surface Ca V 2.2 was normalized to the scrambled AP-1 shRNA control condition in each experiment. The expression of shRNA detected by mCerulean was comparable in all conditions (Ca V 2.2e37a, p ϭ 0.0271; Ca V 2.2e37b, p ϭ 0.0049). C, Confocal images of BBS-tagged Ca V 2.2e37b showing reduced cell surface expression (second panel) in the presence of AP-1 V98S, compared to WT. Scale bar, 20 m. D, Dominant-negative AP-1 V98S mutant significantly reduces cell surface Ca V 2.2e37 isoforms. Cell surface Ca V 2.2 was normalized to the wild-type AP-1 control condition in each experiment. The expression level of myc-tagged AP-1 detected by anti-myc antibody was comparable in all conditions (Ca V 2.2e37a, p Ͻ 0.0001; Ca V 2.2e37b, p Ͻ 0.0001). n, Number of cells. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001 (Student's unpaired t test).
and D 2 dopamine receptors directly interact with Ca V 2.2 via intracellular regions to modulate the channel properties, cell surface expression, and endocytosis (Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008). We therefore coexpressed the Ca V 2.2e37 isoforms (with ␣ 2 ␦-1 and ␤1b), together with D2R in N2a cells, to first determine the effect of D2R on cell surface expression of the two Ca V 2.2e37 isoforms. We found that D2R had no effect on the cell surface expression of Ca V 2.2e37a, and modestly en- (n ϭ 94) ; yellow, YSLL/ASAA (n ϭ 7). Right, Total Ca V 2.2 levels were not significantly different in all conditions. Only a few cells that were expressing Ca V 2.2 from YSLL/ASAA mutation were detected, due to a low expression of Ca V 2.2 in N2a cells. D, Whole-cell current density of AP-binding mutants. The peak current densities at ϩ0 mV are as follows (in pA/pF); WT (red), Ϫ185.7 Ϯ 28.7 (n ϭ 24); L/A (purple), Ϫ103.2 Ϯ 12.8 (n ϭ 27); Y/A (green), Ϫ101.9 Ϯ 18.3 (n ϭ 30); LL/AA (pink), 2.44 Ϯ 0.34 (n ϭ 4). E, G max of AP-binding mutants is also significantly reduced, similarly to the cell surface expression. F, V 50 , act of Ca V 2.2e37a AP-1 binding mutants. V 50 activation was not altered by the mutations [p ϭ 0.27; WT (red), n ϭ 22; L/A (purple), n ϭ 27; Y/A (green), n ϭ 30]. n, Number of cells. *p Ͻ 0.05; ***p Ͻ 0.001 (one-way ANOVA, Bonferroni's post hoc test).
hanced the cell surface expression of Ca V 2.2e37b (Fig. 9A) . Furthermore, upon D2R activation by the specific agonist Quin, the amount of both Ca v 2.2e37 isoforms on the cell surface was significantly reduced by ϳ30% relative to the control within 30 min (Fig. 9 B, C) , which is likely to represent endocytosis. To elucidate the differential effect of D2R on the Ca V 2.2e37 isoform cell surface expression, the rate at which these channels undergo endocytosis with D2R was determined using BBS-tagged Ca V 2.2e37 Right, Cell surface Ca V 2.2 with D2R is normalized to the control condition expressing an empty vector in each experiment. D2R significantly increased cell surface Ca V 2.2e37b ( p ϭ 0.0064), whereas cell surface Ca V 2.2e37a was not affected by D2R ( p ϭ 0.85). B, Left, Cell surface Ca V 2.2e37b in the presence of D2R, with or without 100 nM Quin ( p ϭ 0.0067). Middle, Ca V 2.2e37b endocytosis rate was slowed by the presence of D2R and accelerated by D2R activation (closed blue circle, e37b ϩ D2R; open blue circle, e37b ϩ D2R ϩ Quin; black circle, e37b; from Fig. 5D ). Right, The endocytosis kinetics (black bar, e37b; closed blue bar, e37b ϩ D2R; open blue bar, e37b ϩ D2R ϩ Quin; n ϭ 3 to 5 transfections; p Ͻ 0.05, one-way ANOVA, Bonferroni's post hoc test). C, Left, Cell surface Ca V 2.2e37a in the presence of D2R, with or without 100 nM Quin ( p ϭ 0.0002). Middle, e37a endocytosis was not significantly changed by the presence of D2R nor by D2R activation (closed red circle, e37a ϩ D2R; open red circle, e37a ϩ D2R ϩ Quin; black circle, 37a; from Fig. 5D ). Right, The endocytosis kinetics (black bar, e37a; closed red bar, e37a ϩ D2R; open red bar, e37a ϩ D2R ϩ Quin; n ϭ 3 to 5 transfections). D, Cell surface Ca V 2.2 in the presence of D2R, with or without 100 nM Quin after PTX treatment (37b, p ϭ 0.0019; 37a, p ϭ 0.0302). E, PTX blocks Ca V 2.2 inhibition mediated by D2R activation. PTX treatment removed the inhibition of Ca V 2.2 whole-cell current by 100 nM Quin application to activate D2R [Ca V 2.2e37b control (blue closed squares), n ϭ 23; Ca V 2. isoforms in the presence or absence of Quin, and these rates were compared with the previously determined basal endocytosis without D2R (Fig. 5D , Table 2 ). The endocytosis rate of Ca V 2.2e37b was significantly slowed by the presence of D2R (Fig.  9B , Table 2 ). Ca V 2.2e37b then internalized more rapidly in the presence of Quin, with a value similar to that determined for Ca V 2.2e37b alone. On the other hand, the basal endocytosis rate of Ca V 2.2e37a was not significantly affected by coexpression of D2R, compared to Ca V 2.2e37a alone (Fig. 9C, Table 2 ), as predicted from the previous comparison of cell surface expression levels (Fig. 9A) . In contrast to the effect of Quin to reduce the overall cell surface expression of Ca V 2.2e37a channels, Quin treatment did not significantly accelerate Ca V 2.2e37a endocytosis, possibly reflecting a minimum limit in the determination of endocytosis rate by this protocol.
This effect of Quin was not blocked by pretreatment with PTX ( Fig. 9D) , indicating that D2R activity-mediated endocytosis is independent of the direct action of G ␤␥ on Ca V 2.2, as PTX blocks voltage-dependent inhibition of Ca V 2.2 by Quin (Fig. 9E) . Receptor sequestration has been reported for a number of GPCRs following activation, which is mediated by the recruitment of ␤-arrestin to the activated receptor (Krupnick and Benovic, 1998) . ␤-arrestin targets GPCRs for clathrin-dependent endocytosis by directly interacting with AP-2 (Goodman et al., 1996; Zhang et al., 1996; Laporte et al., 1999 Laporte et al., , 2000 . To test whether blocking clathrin-mediated endocytosis also inhibits D2R activation-induced Ca V 2.2 endocytosis, the dominant-negative mutant of the AP-22 subunit F174A/D176S was coexpressed; this construct has been shown to impair transferrin endocytosis (Motley et al., 2006) . In the presence of the AP-22 mutant, Ca V 2.2 endocytosis was not observed after Quin treatment (Fig.  9F ) . To confirm the involvement of AP-2 in D2R-mediated endocytosis of Ca V 2.2, the endocytosis rates of Ca V 2.2e37a L/A and Y/A mutants with D2R were examined. Quin treatment did not alter the endocytosis of either mutant (Fig. 9G, Table 2 ). These results indicate that disrupting the interaction between AP-2 and Ca V 2.2 blocks D2R agonist-induced endocytosis. In summary, these data suggest that (1) the D2R has a differential effect on Ca V 2.2e37 isoforms at the cell surface, as it reduces the endocytosis rate of Ca V 2.2e37b, but not e37a, and (2) activation of the D2R causes both Ca V 2.2e37 isoforms to internalize via ␤-arrestin-mediated recruitment of clathrin, which requires interaction between AP-2 and Ca V 2.2.
Discussion
AP-1 mediated regulation of Ca V 2.2 splice variant trafficking Ca V 2.2 trafficking is mediated by interaction with its auxiliary subunits and various intracellular proteins (Kaeser et al., 2011; Dolphin, 2012) . Our data demonstrate enhanced trafficking of Ca V 2.2e37a compared to the e37b splice variant, both to the plasma membrane and to neuronal processes where these channels are physiologically important. The 37a exon contains interaction motifs for both the 1 subunit and ␥-1 hemicomplex of AP-1, which are overlapping (DMYSLL). However, an AP-1 complex would be unable to bind both simultaneously due to conformational constraints (Heldwein et al., 2004; . The complete abolition of both motifs severely disrupted trafficking of Ca V 2.2e37a to the cell membrane and DRG neurites, demonstrating the importance of these AP-1 interaction sites in the proximal C terminus of Ca V 2.2. Furthermore, [DE] xxxL [LI] is also present in other voltage-gated calcium channels such as Ca V 1.3, 1.4 and Ca V 2.1(e37a) in the proximal C terminus (Table 3) . On the other hand, the Ca V 2.2e37b splice variant has a noncanonical [DE] xxxL [LI] motif, where L[LI] is substituted by ML (DMEFML), which is indicated to be a less efficient signal compared with the canonical motif (Motta et al., 1995; Hofmann et al., 1999) . In addition, the e37b sequence lacks Yxx⌽. This may explain why Ca V 2.2e37b channels are less efficiently trafficked to the plasma membrane and to the DRG neurites, compared to Ca V 2.2e37a, which contains two strong signals for binding to AP-1 in this exon. Mutating Ca V 2.2e37a from DMYSLL to DMFSLL also reduced the current density, which was indistinguishable from that of Ca V 2.2e37b (Raingo et al., 2007) , supporting this hypothesis.
The proximity of these motifs in the C terminus of Ca V 2.2 to the membrane may also create a favorable site for AP-1 interaction. This has been demonstrated for AP-2, which is recruited to the plasma membrane via phosphatidylinositol 4,5-bisphosphate interaction. This causes AP-2 to undergo a "locked" to "open" conformational change, which exposes its motif-binding sites (Jackson et al., 2010) . Although phosphoinositides such as phosphatidylinositol 4-phosphate, prevalent in the Golgi, are alone insufficient for the recruitment of AP-1, the close proximity of these motifs to the membrane is probably important, as membrane-associated Arf1 brings AP-1 close to the Golgi membrane, where it unlocks the AP-1 conformation to allow for cooperative binding of the cargo and phosphatidylinositol 4-phosphate (Stamnes and Rothman, 1993; Crottet et al., 2002; .
The overlapping nature of the AP-1 binding motifs in Ca V 2.2e37a is unprecedented; however, abolishing either of the binding sites for AP-11 and ␥-1 in Ca V 2.2e37a, by mutating the key amino acids, led to a partial loss of cell surface expression and trafficking to the DRG neurites. This indicates that both of the AP-1 subunits separately have the ability to interact with the overlapping motif in e37a and are able to partially compensate for the trafficking defect in the e37a single mutants, when only one of the potential binding sites is available. However, when both motifs are available for interaction, one of the AP-1 subunits may have a higher affinity than the other toward its corresponding motif, to mediate more efficient trafficking in a native state. Moreover, other intracellular regions of Ca V 2.2 also contain possible interaction sites for APs. For example, there is one Yxx⌽ motif in the N terminus (Y59) and two in the II-III loop (Y811 and Y1154), whereas there is only one other [DE] xxxL [LI] site, which is in the distal C terminus (E2256) in Ca V 2.2. All of these sites are conserved in human, mouse, rat, rabbit, and chicken Ca V 2.2. In the case of AP-2, binding to [DE] xxxL [LI] , Yxx⌽, and phosphatidylinositol 4,5-bisphosphate is essential for ensuring its high affinity for the cargo in the membrane (Jackson et al., 2010) . Ca V 2.2e37a may be able to present both motifs in the e37a sequence to the AP-1 complex studied here, and as a result the AP-1 complex is able to interact with the conformationally most favorable counterpart motif for mediating effective trafficking. No mutational or interaction studies have been conducted on the other sites in Cav2.2 so far, and it will The ͓DE͔xxxL͓LI͔ and Yxx⌽ motifs in the proximal C-terminus of Ca V channels are indicated in bold.
now be important to investigate the involvement of these sites in AP-mediated trafficking. Although it is not clear which AP-1 subunit mediates trafficking more effectively in the native state, it has been shown for AP-2 that it interacts with Yxx⌽ with a higher affinity than [DE] xxxL [LI] (Jackson et al., 2010) . This was also found in our experiments where the Ca V 2.2e37a Y/A mutant showed a markedly slower endocytosis rate, indicating that the Yxx⌽ motif may also interact with AP-22 subunits, which are involved predominantly in clathrin-mediated endocytosis (Nesterov et al., 1999) . Our findings suggest that in the case of endocytosis, Yxx⌽ may play a more important role than [DE] xxxL [LI] in mediating Ca V 2.2 endocytosis.
Both shRNA knockdown of AP-1␥ and expression of the dominant-negative AP-1 mutant V98S reduced trafficking of both isoforms to the plasma membrane. This provides direct evidence for AP-1 mediating trafficking for both isoforms of Ca V 2.2, e37a and e37b. Although other possible AP-interaction sites mentioned above potentially mediate Ca V 2.2 trafficking, the differential trafficking observed between the e37 isoforms in this study suggests that this particular motif may play a more important role than the others. Nevertheless, incomplete inhibition suggests that Ca V 2.2 trafficking may also involve non-clathrinmediated mechanisms, such as lipid raft-and caveolae-mediated trafficking (Le Roy and Wrana, 2005; Parton and Simons, 2007) . Indeed, Ca V 2 channels colocalize with caveolin and flotillin-1 in the presence of ␤ and ␣ 2 ␦ subunits, and are present in lipid rafts (Davies et al., 2006; Robinson et al., 2010) . Overexpression studies of AP-1 dominant-negative mutants have indicated previously that AP-1 mediates somatodendritic trafficking of transmembrane receptors in central neurons such as hippocampal neurons (Farías et al., 2012; Jain et al., 2015) . Our Ca V 2.2e37a AP-1 binding site mutants demonstrate that AP-1 may also play an important role in axonal trafficking in DRG neurons, since these are pseudounipolar and do not form dendrites, and therefore binding of AP-1 to these sites may modulate the presence of these channels at the presynaptic membrane.
Interaction between Ca V 2.2 splice variants and dopamine receptors and effects of receptor activation Direct interaction between Ca V 2.2 and dopamine receptors may be important in regulating the surface expression of Ca V 2.2 ( Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008) . We find in N2a cells that coexpression of D2R does not increase the cell-surface expression of Ca V 2.2e37a and produces only a modest increase for Ca V 2.2e37b. Our results show that the rate of endocytosis of Ca V 2.2e37b is considerably slowed by the D2R; thus, the channels are more stable and they accumulate at the cell surface. Surprisingly, this stabilizing effect at the plasma membrane diminishes upon D2R activation, and Ca V 2.2e37b internalizes at an increased rate similar to that for the channel expressed in the absence of the receptor.
There are two possible explanations for this observation: (1) the activated D2R-Ca V 2.2 complex internalizes together at an accelerated rate; (2) the activated D2R undergoes a conformational change and dissociates from Ca V 2.2 at the cell surface, and they internalize separately at their own native rates. How D 2 receptors decrease the endocytosis rate of Ca V 2.2e37b channels is still not clear; however, the colocalization of Ca V 2.2 and D2R via direct interaction of their intracellular regions suggested previously (Kisilevsky and Zamponi, 2008) implies that APs may be able to bind to the cargo motifs in Ca V 2.2 and D2R simultaneously to regulate their cotrafficking. Indeed, the D2R contains Yxx⌽ motifs in its intracellular loops 2 and 3 near the plasma membrane, but does not contain [DE] xxxL [LI] (Namkung and Sibley, 2004) . In the case of endocytosis, the AP-2 subunit could potentially interact with either of these Yxx⌽ motifs in D2R, whereas the AP-2 ␣-2 hemicomplex could interact with the DxxxML motif in the e37b sequence to mediate their cointernalization from the cell surface. Our data support this concept, since mutating the DxxxLL motif in Ca V 2.2e37a to DxxxAL slows its endocytosis only in the additional presence of the D2R, whereas mutating Yxx⌽ motif in the C terminus of Ca V 2.2e37a does not (Fig. 9C,G, Table 2 ). We have also noted that the N terminus of Ca V 2.2 contains another Yxx⌽ motif, and this is adjacent to the region important for G-protein modulation (Page et al., 1998) . Furthermore, upon D2R activation, ␤-arrestin may be recruited to the activated D2R, where it acts as an adaptor for AP-2-mediated endocytosis (Goodman et al., 1996; Laporte et al., 2000 Laporte et al., , 2002 Lan et al., 2009 ). Here we provide new evidence that disrupting the recruitment of functional AP-2 by overexpressing the dominant-negative mutant AP-22 and mutations in [DE] xxxL [LI] and Yxx⌽ motifs inhibit Ca V 2.2 endocytosis upon D2R activation, demonstrating that AP-2 is required for Ca V 2.2 endocytosis mediated by D2R activation.
In summary, our data demonstrate novel evidence that Ca V 2.2 trafficking in cell bodies and neurites is fine-tuned by alternative splicing of exon 37, and is mediated differentially by AP-1. Furthermore, alternative splicing of exon 37 also modulates the effect on trafficking of Ca V 2.2 resulting from D2R interaction and activation. Blocking the interaction of APs with the binding motif in the proximal C terminus of Ca V 2.2 may modulate calcium entry into neurons and the response to dopamine receptor activation.
